Literature DB >> 12730503

Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.

O Vittecoq1, S Pouplin, K Krzanowska, F Jouen-Beades, J F Menard, A Gayet, A Daragon, F Tron, X Le Loet.   

Abstract

OBJECTIVE: To evaluate the predictive value of clinical, biological and radiological parameters for the prognosis of rheumatoid arthritis (RA) in a community-recruited cohort.
METHODS: Ninety-one patients (mean age 49 yr, female/male ratio 2.9) with RA of limited duration (median 2 yr), 80% recruited from the community, were prospectively enrolled in 1996 (T1) and followed until 1999 (T2). Data collected at T1 were demographic characteristics, Ritchie articular index (RAI), extra-articular manifestations, Health Assessment Questionnaire (HAQ) score, C-reactive protein (CRP) and autoantibodies (autoAbs) [rheumatoid factors (RF), detected by latex fixation test and ELISA (IgM, IgA and IgG isotypes), anti-filaggrin, detected by immunofluorescence (anti-keratin antibodies, AKA; anti-perinuclear factor antibodies, APF) and ELISA (anti-citrullinated rat filaggrin antibodies, ACRFA), anti-Sa, anti-calpastatin recognizing the 27 C-terminal fragment (ACAST-C27) and domain I (ACAST-DI), anti-cardiolipin (ACL), antineutrophil cytoplasmic antibodies (ANCA), anti-annexin V (aANX V) and anti-Ro]. Hands were radiographed at T1 and T2, and read using the Sharp method as modified by van der Heijde. The main assessment criterion was progression of radiologically detected damage between T1 and T2.
RESULTS: At T1, RA activity was mild (RAI 11/78; mean CRP 14 mg/ml), with minor functional disability (HAQ 0.8/3) and mild X-ray destruction (mean total Sharp score 9.2/280). At T1, 96% of the patients were on treatment (prednisone 72%, DMARDs 95%). The latex test detected autoAb in 46% of patients, RF-IgM was detected in 51%, RF-IgA in 36%, RF-IgG in 32%, AKA in 33%, APF in 45%, ACRFA in 45%, ACAST-C27 in 14%, ACAST-DI in 5%, anti-Sa in 22%, ACL in 3%, ANCA in 28%, aANX V in 9% and anti-Ro in 2%. At T2, the mean total Sharp score was 22.9. According to univariate analysis, T1 parameters associated with the independent variable were RAI, HAQ, CRP, latex test positivity and T1 Sharp scores. Multivariate analysis retained only latex test positivity and, to a lesser degree, joint-space narrowing score as independent predictors of radiological progression.
CONCLUSION: RF is the main factor that can predict radiological progression in community cases of RA of limited duration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730503     DOI: 10.1093/rheumatology/keg257

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  28 in total

1.  Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study.

Authors:  Aşkin Ateş; Gülay Kinikli; Murat Turgay; Gülay Akay; Güner Tokgöz
Journal:  Clin Rheumatol       Date:  2006-06-28       Impact factor: 2.980

2.  MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis.

Authors:  Zhi-Dan Fan; Qian Cao; Na Huang; Le Ma; Hui-Hui Ma; Ya-Yuan Zhang; Hai-Guo Yu; Guo-Ping Zhou
Journal:  World J Pediatr       Date:  2019-05-17       Impact factor: 2.764

3.  Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.

Authors:  Sumeet Agrawal; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

4.  Radiographic estimation in seropositive and seronegative rheumatoid arthritis.

Authors:  Vjollca Sahatçiu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kërliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

5.  Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.

Authors:  F Jouen; O Vittecoq; F Leguillou; I Tabti-Titon; J F Menard; O Mejjad; S Pouplin; P Boumier; P Fardellone; A Gayet; D Gilbert; F Tron; X Le Loët
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 6.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

7.  Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.

Authors:  M Güler-Yüksel; J Bijsterbosch; Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; H K Ronday; A J Peeters; J M de Jonge-Bok; F C Breedveld; B A C Dijkmans; C F Allaart; W F Lems
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

8.  Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Authors:  R A Burgos; J L Hancke; J C Bertoglio; V Aguirre; S Arriagada; M Calvo; D D Cáceres
Journal:  Clin Rheumatol       Date:  2009-04-29       Impact factor: 2.980

9.  Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.

Authors:  J-Y Chen; C-M Wang; J-M Wu; H-H Ho; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.

Authors:  R Westhovens; M Robles; A C Ximenes; S Nayiager; J Wollenhaupt; P Durez; J Gomez-Reino; W Grassi; B Haraoui; W Shergy; S-H Park; H Genant; C Peterfy; J-C Becker; A Covucci; R Helfrick; J Bathon
Journal:  Ann Rheum Dis       Date:  2009-01-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.